Cardiac Science to Present at the 10th Annual Needham & Company Growth Conference |
(Archive News Story - Products mentioned in this Archive News Story may or may not be available from the manufacturer.)
Cardiac Science Inc.
3303 Monte Villa Pkwy.
Everett, WA, 98201
USA
Press release date: January 2, 2008
BOTHELL, Wash., Jan. 2 -- Cardiac Science Corporation (NASDAQ:CSCX), a global leader in advanced cardiac monitoring and defibrillation products, announced today that it will present at the 10th Annual Needham & Company, LLC Growth Conference at the New York Palace Hotel on Tuesday, January 8, 2008, at 1:30 p.m. Eastern Time. Michael Matysik, senior vice president and chief financial officer, will review the Company's business strategy and recent financial results.
Attendance at the conference is by invitation only. Cardiac Science will offer a live audio webcast of its presentation, which may be accessed at the Company's website at http://www.cardiacscience.com/. An archived replay of the presentation will also be available following the live presentation and can be accessed at http://www.cardiacscience.com/ for 90 days.
About Cardiac Science Corporation
Cardiac Science is truly at the heart of saving lives. The Company develops, manufactures, and markets a family of advanced diagnostic and therapeutic cardiology devices and systems, including AEDs, electrocardiographs, stress test systems, Holter monitoring systems, hospital defibrillators, cardiac rehabilitation telemetry systems, patient monitor - defibrillators and cardiology data management systems. Cardiac Science also sells a variety of related products and consumables, and provides a comprehensive portfolio of training, maintenance and support services. The Company is the successor to various entities that have owned and operated cardiology-related businesses that sold products under the trusted brand names Burdick®, Powerheart®, and Quinton®. Cardiac Science is headquartered in Bothell, WA, and also has operations in California and Wisconsin, China, Denmark, France and the United Kingdom.
Company Contact: Mike Matysik Cardiac Science Corporation Chief Financial Officer 425-402-2206
Investor Contact: EVC Group, Inc. Douglas Sherk/Jenifer Kirtland 415-896-6820
Media Contact: EVC Group, Inc. Steve DiMattia 646-277-8706
Source: Cardiac Science Corporation
Web site: http://www.cardiacscience.com/
|
|
|
|
|
|
| 
